Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Roberto Hegg | Researchclopedia

Back to researchers

Roberto Hegg

Universidade de São Paulo ORCID

181

Works

19,151

Citations

40

h-index

59

i10-index

Research Topics

HER2/EGFR in Cancer Research Advanced Breast Cancer Therapies Breast Cancer Treatment Studies

Affiliations

Roche (Switzerland)2021–2021

MedStar Washington Hospital Center2011–2011

Seoul National University2011–2011

Universidade de São Paulo1987–2025

Heidelberg University2011–2011

Top Works

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Peter Schmid,Sylvia Adams,et al.

20184,270 citations

Cancer Treatment and Pharmacology

Women's cancer prevention and management

Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer

José Baselga,Javier Cortés,et al.

20112,496 citations

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés,David W. Cescon,et al.

20201,746 citations

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)

Andreas Schneeweiß,Stephen Chia,et al.

20131,244 citations

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

Elizabeth A. Mittendorf,Hong Zhang,et al.

20201,031 citations

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain,David Miles,et al.

2020866 citations

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

David Miles,Joseph Gligorov,et al.

2021704 citations

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial

Sara A. Hurvitz,Roberto Hegg,et al.

2022595 citations

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

Nadia Harbeck,Priya Rastogi,et al.

2021370 citations